MB, Levis & Associates’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

MB, Levis & Associates’s Portfolio IBDW Stock Details IBDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375	Sell	18 -657,345	-100%	-$13.7M	﹤0.01%	248
2026 Q1	$13.8M	Buy	657,363 +6,869	+1%	+$145K	5.74%	5
2025 Q4	$13.8M	Buy	650,494 +10,086	+2%	+$214K	5.79%	5
2025 Q3	$13.6M	Buy	640,408 +1,681	+0.3%	+$35.4K	5.88%	6
2025 Q2	$13.4M	Buy	638,727 +10,028	+2%	+$207K	5.9%	6
2025 Q1	$13M	Buy	628,699 +3,518	+0.6%	+$72.2K	6.06%	6
2024 Q4	$12.7M	Buy	625,181 +9,580	+2%	+$198K	6.37%	5
2024 Q3	$13.1M	Buy	615,601 +10,076	+2%	+$210K	6.44%	5
2024 Q2	$12.3M	Buy	605,525 +16,530	+3%	+$334K	6.46%	5
2024 Q1	$12.1M	Buy	588,995 +12,825	+2%	+$262K	6.48%	5
2023 Q4	$12M	Buy	576,170 +33,847	+6%	+$667K	6.85%	5
2023 Q3	$10.5M	Buy	542,323 +9,455	+2%	+$188K	6.82%	7
2023 Q2	$10.8M	Buy	532,868 +84,175	+19%	+$1.72M	6.92%	6
2023 Q1	$9.26M	Buy	448,693 +42,498	+10%	+$867K	6.44%	6
2022 Q4	$8.08M	Buy	+406,195	New	+$8.04M	6.32%	7

Other funds holding IBDW

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

VVP

Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SVWA

Sarver Vrooman Wealth Advisors Kansas City, Missouri $168M AUM 7.75% 1-Year Est. Return

MB, Levis & Associates's IBDW Position: Q2 2026 in Review

MB, Levis & Associates reduced its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 100% in Q2 2026, selling an estimated $13.7M and leaving 18 shares worth $375. The position accounts for ﹤0.01% of the portfolio, ranked #248.

MB, Levis & Associates first reported a position in IBDW in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.8M in Q1 2026. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

MB, Levis & Associates held 18 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $375 as of Q2 2026.
MB, Levis & Associates sold 657,345 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $13.7M.
iShares iBonds Dec 2031 Term Corporate ETF made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #248 holding.
MB, Levis & Associates first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2022 and has held it in 15 quarters since.
MB, Levis & Associates's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $13.8M in Q1 2026.
290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.